Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2026-02-25 @ 11:49 PM
Study NCT ID:
NCT06397703
Status:
RECRUITING
Last Update Posted:
2025-03-26
First Post:
2024-04-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
Sponsor:
NYU Langone Health
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
23-01267
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None